Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 VL Feigin, E Nichols, T Alam, MS Bannick, E Beghi, N Blake, ... The Lancet Neurology 18 (5), 459-480, 2019 | 1760 | 2019 |
Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 G Logroscino, M Piccininni, B Marin, E Nichols, F Abd-Allah, A Abdelalim, ... The Lancet Neurology 17 (12), 1083-1097, 2018 | 231 | 2018 |
COVID‐19 vaccine‐associated cerebral venous thrombosis in Germany JB Schulz, P Berlit, HC Diener, C Gerloff, A Greinacher, C Klein, ... Annals of neurology 90 (4), 627-639, 2021 | 153 | 2021 |
Public perspectives on protective measures during the COVID-19 pandemic in the Netherlands, Germany and Italy: A survey study K Meier, T Glatz, MC Guijt, M Piccininni, M Van Der Meulen, K Atmar, ... PloS one 15 (8), e0236917, 2020 | 146 | 2020 |
Amyotrophic lateral sclerosis descriptive epidemiology: the origin of geographic difference G Logroscino, M Piccininni Neuroepidemiology 52 (1-2), 93-103, 2019 | 119 | 2019 |
Giving researchers a headache–sex and gender differences in migraine L Al-Hassany, J Haas, M Piccininni, T Kurth, A Maassen Van Den Brink, ... Frontiers in neurology 11, 549038, 2020 | 110 | 2020 |
Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life F Panza, M Lozupone, R Sardone, P Battista, M Piccininni, V Dibello, ... Therapeutic advances in chronic disease 10, 2040622318811000, 2019 | 99 | 2019 |
Italy's health performance, 1990–2017: findings from the global burden of disease study 2017 L Monasta, C Abbafati, G Logroscino, G Remuzzi, N Perico, B Bikbov, ... The Lancet Public Health 4 (12), e645-e657, 2019 | 80 | 2019 |
Use of all cause mortality to quantify the consequences of covid-19 in Nembro, Lombardy: descriptive study M Piccininni, JL Rohmann, L Foresti, C Lurani, T Kurth bmj 369, 2020 | 71 | 2020 |
Plasma inflammatory cytokines are elevated in ALS R Tortelli, C Zecca, M Piccininni, S Benmahamed, MT Dell'Abate, ... Frontiers in neurology 11, 552295, 2020 | 61 | 2020 |
Directed acyclic graphs and causal thinking in clinical risk prediction modeling M Piccininni, S Konigorski, JL Rohmann, T Kurth BMC medical research methodology 20 (1), 1-9, 2020 | 54 | 2020 |
Social dysfunction in older age and relationships with cognition, depression, and apathy: the GreatAGE study M Lozupone, F Panza, M Piccininni, M Copetti, R Sardone, BP Imbimbo, ... Journal of Alzheimer's Disease 65 (3), 989-1000, 2018 | 47 | 2018 |
Primary progressive aphasia: a review of neuropsychological tests for the assessment of speech and language disorders P Battista, A Miozzo, M Piccininni, E Catricala, R Capozzo, R Tortelli, ... Aphasiology 31 (12), 1359-1378, 2017 | 35 | 2017 |
Incidence of frontotemporal lobar degeneration in Italy: The Salento-Brescia Registry study G Logroscino, M Piccininni, G Binetti, C Zecca, R Turrone, R Capozzo, ... Neurology 92 (20), e2355-e2363, 2019 | 34 | 2019 |
Referral bias in ALS epidemiological studies G Logroscino, B Marin, M Piccininni, S Arcuti, A Chio, O Hardiman, ... PLoS One 13 (4), e0195821, 2018 | 33 | 2018 |
Incidence of syndromes associated with frontotemporal lobar degeneration in 9 European countries G Logroscino, M Piccininni, C Graff, O Hardiman, AC Ludolph, F Moreno, ... JAMA neurology 80 (3), 279-286, 2023 | 25 | 2023 |
Screening for aphasia in neurodegeneration for the diagnosis of patients with primary progressive aphasia: clinical validity and psychometric properties P Battista, E Catricalà, M Piccininni, M Copetti, V Esposito, C Polito, ... Dementia and geriatric cognitive disorders 46 (3-4), 243-252, 2018 | 22 | 2018 |
Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real … R Depenni, MC Rocca, D Ferrari, G Azzarello, C Baldessari, M Alù, F Nolé, ... European Journal of Cancer 115, 4-12, 2019 | 20 | 2019 |
Plasma β-amyloid1–42 reference values in cognitively normal subjects C Zecca, R Tortelli, F Panza, S Arcuti, M Piccininni, R Capozzo, ... Journal of the neurological sciences 391, 120-126, 2018 | 20 | 2018 |
Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019 A Raggi, L Monasta, E Beghi, V Caso, G Castelpietra, S Mondello, ... Journal of neurology, 1-19, 2022 | 19 | 2022 |